Related Experiment Video
Updated: Jun 27, 2026

A Strategy for Sensitive, Large Scale Quantitative Metabolomics
Published on: May 27, 2014
Quantitative mass spectrometry-based techniques for clinical use: biomarker identification and quantification.
Kathryn L Simpson1, Anthony D Whetton, Caroline Dive
1Paterson Institute for Cancer Research, University of Manchester, Wilmslow Road, Manchester, M20 4BX, United Kingdom. KSimpson@PICR.man.ac.uk
Personalized medicine advances with novel biomarker discovery using mass spectrometry (MS). MS techniques overcome challenges in analyzing blood proteins for improved patient care and disease diagnosis.
Area of Science:
- Clinical proteomics
- Biomarker discovery
- Mass spectrometry applications
Background:
- Personalized medicine holds promise for enhanced patient care through novel biomarker identification.
- Blood-derived biomarkers (plasma, serum) are highly sought after due to ease of sampling.
- Significant advancements in mass spectrometry (MS), separation techniques, and bioinformatics are enabling high-throughput proteomic analysis.
Purpose of the Study:
- To review MS-based methods for clinical proteomic analysis.
- To highlight progress and challenges in biomarker discovery and validation.
- To discuss the potential of MS in advancing personalized medicine.
Main Methods:
- High-throughput mass spectrometry for protein identification and quantification.
- Liquid phase analyte separation techniques.
- Bioinformatic tools for data analysis.
- Sensitive MS-based methods for biomarker validation, potentially bypassing antibody requirements.
Main Results:
- MS techniques can overcome the dynamic range challenges in plasma proteome analysis.
- Deep mining of the blood proteome is feasible for identifying novel biomarker signatures.
- MS-based validation offers a potential solution to the antibody bottleneck in large-scale screening.
Conclusions:
- Mass spectrometry is a powerful tool for identifying and validating novel biomarkers for personalized medicine.
- Overcoming current challenges will facilitate the clinical application of proteomic discoveries.
- Continued research in MS-based clinical proteomics is crucial for advancing patient care.
More Related Videos
11:09An HS-MRM Assay for the Quantification of Host-cell Proteins in Protein Biopharmaceuticals by Liquid Chromatography Ion Mobility QTOF Mass Spectrometry
Published on: April 17, 2018
09:58Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples
Published on: January 7, 2019
Related Concept Videos
MALDI-TOF Mass Spectrometry
Tandem Mass Spectrometry
Mass Spectrometry: Complex Analysis
GC–MS is a powerful hyphenated method commonly used in forensics and environmental...
Peptide Identification Using Tandem Mass Spectrometry
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
Rapid Identification of Pathogens
Mass Spectrometry: Overview